Inventor · disambiguated record
Nigel H. Greig
Also filed as: GREIG NIGEL · GREIG NIGEL H
27 granted patents·11 pending applications·436 citations·filing 1987–2021
97Inventor score
Files withUS HEALTH12GREIG NIGEL H9AXONYX INC2PEPTRON INC2THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2
Top patents by PatentIndex Score
38 records- 0193US11440880B2Thalidomide analogs and methods of useTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Sep 13, 2022·5 cites·20 claims
- 0293US8691864B2Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereofGREIG NIGEL H·Filed 2012·Granted Apr 8, 2014·13 cites·25 claims
- 0393US8258172B2Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereofGREIG NIGEL H·Filed 2010·Granted Sep 4, 2012·11 cites·25 claims
- 0492US8853160B2GLP-1, exendin-4, peptide analogs and uses thereofGREIG NIGEL H·Filed 2012·Granted Oct 7, 2014·22 cites·20 claims
- 0591US5171750ASubstituted phenserines as specific inhibitors of acetylcholinesteraseUS HEALTH·Filed 1991·Granted Dec 15, 1992·56 cites·14 claims
- 0690US7786162B2Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereofRAPTOR PHARMACEUTICAL CORP·Filed 2009·Granted Aug 31, 2010·11 cites·21 claims
- 0790US7576050B2GLP-1 exendin-4 peptide analogs and uses thereofUS HEALTH·Filed 2002·Granted Aug 18, 2009·39 cites·15 claims
- 0889US8278272B2GLP-1, exendin-4, peptide analogs and uses thereofGREIG NIGEL·Filed 2008·Granted Oct 2, 2012·18 cites·24 claims
- 0988US7973057B2Thalidomide analogsUS HEALTH·Filed 2004·Granted Jul 5, 2011·30 cites·11 claims
- 1088US6683105B2Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementiasAXONYX INC·Filed 2002·Granted Jan 27, 2004·34 cites·7 claims
- 1186US7153882B2Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereofNAT INST OF HEALTH AND AXONYX·Filed 2001·Granted Dec 26, 2006·21 cites·157 claims
- 1285US9623020B2Thio compoundsUS HEALTH·Filed 2015·Granted Apr 18, 2017·5 cites·3 claims
- 1384US8927725B2Thio compoundsGREIG NIGEL H·Filed 2011·Granted Jan 6, 2015·7 cites·5 claims
- 1484US7056734B1Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereofUS HEALTH·Filed 1999·Granted Jun 6, 2006·50 cites·40 claims
- 1580US10836721B2Thalidomide analogs and methods of useTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Nov 17, 2020·1 cites·20 claims
- 1674US8546430B2Thalidomide analogsGREIG NIGEL H·Filed 2011·Granted Oct 1, 2013·2 cites·19 claims
- 1773US6410747B1Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementiasUS HEALTH·Filed 1998·Granted Jun 25, 2002·28 cites·6 claims
- 1871US11771657B2Methods of delivering a neuroprotective polypeptide to the central nervous systemPEPTRON INC·Filed 2021·Granted Oct 3, 2023·0 cites·11 claims
- 1971US5378723ACarbamate analogs of thiaphysovenine and method for inhibiting cholinesterasesUS HEALTH·Filed 1994·Granted Jan 3, 1995·24 cites·14 claims
- 2069US5409948AMethod for treating cognitive disorders with phenserineUS HEALTH·Filed 1992·Granted Apr 25, 1995·40 cites·6 claims
- 2167US10941187B2GLP-1, exendin-4, peptide analogs and uses thereofTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2014·Granted Mar 9, 2021·0 cites·16 claims
- 2267US2006270729A1Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereofGREIG NIGEL H·Filed 2006·Application pending·0 cites
- 2362US11273130B2Methods of delivering a neuroprotective polypeptide to the central nervous systemPEPTRON INC·Filed 2017·Granted Mar 15, 2022·0 cites·39 claims
- 2459US8853253B2Thalidomide analogsGREIG NIGEL H·Filed 2012·Granted Oct 7, 2014·0 cites·15 claims
- 2558US10220028B2Thio compoundsUS HEALTH·Filed 2017·Granted Mar 5, 2019·0 cites·4 claims
- 2658US5998460APhenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereofUS HEALTH·Filed 1993·Granted Dec 7, 1999·16 cites·17 claims
- 2756US10730835B2Thalidomide analogs and methods of useUS HEALTH·Filed 2016·Granted Aug 4, 2020·0 cites·18 claims
- 2854US2008319032A1Tetrahydrobenzothiazole analogues as neuroprotective agentsGREIG NIGEL H·Filed 2007·Application pending·0 cites
- 2951US2014309436A1Thalidomide analogsP2D INC·Filed 2014·Application pending·0 cites
- 3049US2006105940A1Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methodsAXONYX INC·Filed 2005·Application pending·0 cites
- 3148US2007041951A1Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereofEGAN JOSEPHINE·Filed 2006·Application pending·0 cites
- 3247US2010144704A1Method of reducing amyloid-beta peptide levels using a bisdioxopiperazineGREIG NIGEL H·Filed 2007·Application pending·0 cites
- 3346US2007167509A1Use of phenserine and analogs to treat behavioral problems and improve trainabilityARAUJO JOSEPH·Filed 2006·Application pending·0 cites
- 3446US2010105707A1Method of treating or preventing oxidative stress-related diseaseUSA·Filed 2007·Application pending·0 cites
- 3543US2002025313A1Targeting of liposomes to the blood-brain barrierFiled 2001·Application pending·0 cites
- 3643US2004067991A1Tetrahydrobenzothiazole analogues as neuroprotective agentsFiled 2001·Application pending·0 cites
- 3741US4835182AEnhancing drug delivery to the brainUS HEALTH·Filed 1987·Granted May 30, 1989·3 cites·8 claims
- 3838US2004024043A1Method for treating cognitive disordersFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nigel H. Greig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →